title: Ghost Pills: A Case Report.
authors.affiliation: From University College London Hospitals NHS Foundation Trust and UCL Huntington's Disease Centre, London, United Kingdom.
authors.forename: Desiree M
authors.initials: DM
authors.lastname: Salanio
authors.affiliation: From University College London Hospitals NHS Foundation Trust and UCL Huntington's Disease Centre, London, United Kingdom.
authors.forename: Rachel
authors.initials: R
authors.lastname: Taylor
authors.affiliation: From University College London Hospitals NHS Foundation Trust and UCL Huntington's Disease Centre, London, United Kingdom.
authors.forename: Joel E D
authors.initials: JED
authors.lastname: Stanton
authors.affiliation: From University College London Hospitals NHS Foundation Trust and UCL Huntington's Disease Centre, London, United Kingdom.
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Wild
mesh_terms: D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage*; D001007:Anxiety / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D003863:Depression / Q000188:drug therapy*; D005243:Feces; D006801:Humans; D006816:Huntington Disease / Q000150:complications; D008297:Male; D000069470:Venlafaxine Hydrochloride / Q000008:administration & dosage*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D003692:Delayed-Action Preparations; D000069470:Venlafaxine Hydrochloride